Literature DB >> 19434214

The effect of administration of amodiaquine on some parameters of neurobehaviour of Wistar rats.

M B Ekong1, A O Igiri, O E Mesembe.   

Abstract

The effect of administration of amodiaquine (AQ) on some parameters of neurobehaviour of Wistar rats was carried out. Twenty adult Wistar rats weighing between 160-190g were divided equally into four groups. Group 1 served as the control, while groups 2, 3 and 4 were the experimental groups. The control group received distilled water. Groups 2 and 3 were treated with 8.75mg/kg and 17.50mg/kg respectively of amodiaquine for three days, while group 4 was treated with 8.75mg/kg of AQ for six days. Neurobehaviour test using the open field was carried out twelve hours after the last administrations. There were no significant differences between the control and the experimental groups in total locomotor activity (TLA), central square duration (CSD), stretch-attend (SA) and defecation. In the central square frequency (CSF), group 3 was significantly [P < 0.05] higher than all the groups, while the control was the same as group 4, but higher than group 2, with the difference not being significant. In conclusion, amodiaquine increased TLA and exploration, while simultaneously reducing anxiety in Wistar rats and these were dose dependent.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19434214     DOI: 10.4314/njps.v23i1-2.54924

Source DB:  PubMed          Journal:  Niger J Physiol Sci        ISSN: 0794-859X


  1 in total

1.  Safety and tolerability of artesunate-amodiaquine, artemether-lumefantrine and quinine plus clindamycin in the treatment of uncomplicated Plasmodium falciparum malaria in Kinshasa, the Democratic Republic of the Congo.

Authors:  Yves Lula Ntamba; Hypolite Muhindo Mavoko; Marion Kalabuanga; Blaise Fungula; Pierre-Michel Ntamabyaliro Nsengi; Gaston Tona Lutete; Raquel Inocencio da Luz; Jean-Pierre Van Geertruyden; Pascal Lutumba
Journal:  PLoS One       Date:  2019-09-17       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.